Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rescue Quadratus Lumborum Blocks for Post-cesarean Pain
NCT04397458Phase 4Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Jan 2022
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, dexamethasone in Post-cesarean pain, sponsored by UTHealth Houston. Planned start Jan 2022; status: withdrawn.
02
Drugs
bupivacainedexamethasone
03
Conditions
Post-cesarean pain
Beyond the preview
Go deeper on NCT04397458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04397458.